Table 2.

Ongoing clinical trials of BCG as a mitigation factor against COVID-19.

ID	Phase	Country	Time	Enrollment	Subjects	Sponsor	BCG strain
NCT04328441	III	Netherlands	Mar. 2020	1500	Healthy Adult (HCW)	UMC Utrecht	Danish strain 1331
NCT04327206	III	Australia/Spain	Mar. 2020	10078	Healthy Adult (HCW)	Murdoch Childrens Research Institute	Danish strain 1331
NCT04348370	V	USA	Apr. 2020	1800	Healthy Adult (HCW)	Texas A&M University	Tice strain
NCT04417335	V	Netherlands	Apr. 2020	2014	Healthy Adult (≥60 years)	Radboud University	Danish strain 1331
NCT04362124	III	Colombia	Apr. 2020	1000	Healthy Adult (HCW)	Universidad de Antioquia	BCG Liofilizada
NCT04350931	III	Egypt	Apr. 2020	900	Healthy Adult (HCW)	Ain Shams University	Danish Strain 1331
NCT04373291	III	Denmark	May 2020	1500	Healthy Adult (HCW)	University of Southern Denmark Bandim Health Project	Danish strain 1331
NCT04414267	V	Greece	May 2020	900	Healthy Adult (≥50 years)	Hellenic Institute for the Study of Sepsis	Moscow strain 361-1
NCT04379336	III	South Africa	May 2020	500	Healthy Adult (HCW)	TASK Applied Science	Danish strain 1331
NCT04384549	III	France	May 2020	1120	Healthy Adult (HCW)	Assistance Publique - Hôpitaux de Paris	NA
NCT04475302	III	India	Jul. 2020	2175	Healthy Adult (≥60 years)	Tuberculosis Research Center, India	SII strain
NCT04461379	III	Mexico	Jul. 2020	908	Healthy Adult (HCW)	Hospital Universitario	Tokyo 172 strain
NCT04537663	V	Netherlands	Aug. 2020	5200	Healthy Adult (≥60 years)	UMC Utrecht	Danish strain 1331
NCT04369794	V	Brazil	Aug. 2020	1000	Healthy Adult (≥18 years)	University of Campinas	NA
NCT04534803	III	USA	Sep. 2020	2100	Healthy Adult (≥60 years)	Harvard Medical School	Tokyo 172 strain
NCT04542330	III	Denmark	Sep. 2020	1900	Healthy Adult (≥65 years)	Bandim Health Project	Danish strain 1331

ID ClinicalTrials.gov Identifier, HCW Health Care Workers, NA not available, SII Serum Institute of India.